173 related articles for article (PubMed ID: 24139199)
1. Illicit use of methadone and buprenorphine among adolescents and young adults in Sweden.
Richert T; Johnson B
Harm Reduct J; 2013 Oct; 10():27. PubMed ID: 24139199
[TBL] [Abstract][Full Text] [Related]
2. Diversion of methadone and buprenorphine by patients in opioid substitution treatment in Sweden: prevalence estimates and risk factors.
Johnson B; Richert T
Int J Drug Policy; 2015 Feb; 26(2):183-90. PubMed ID: 25465344
[TBL] [Abstract][Full Text] [Related]
3. Non-prescribed use of methadone and buprenorphine prior to opioid substitution treatment: lifetime prevalence, motives, and drug sources among people with opioid dependence in five Swedish cities.
Johnson B; Richert T
Harm Reduct J; 2019 May; 16(1):31. PubMed ID: 31046774
[TBL] [Abstract][Full Text] [Related]
4. Long-term self-treatment with methadone or buprenorphine as a response to barriers to opioid substitution treatment: the case of Sweden.
Richert T; Johnson B
Harm Reduct J; 2015 Feb; 12():1. PubMed ID: 25889208
[TBL] [Abstract][Full Text] [Related]
5. 'Diversion' of methadone or buprenorphine: 'harm' versus 'helping'.
Havnes IA; Clausen T; Middelthon AL
Harm Reduct J; 2013 Oct; 10():24. PubMed ID: 24131626
[TBL] [Abstract][Full Text] [Related]
6. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence.
Mattick RP; Breen C; Kimber J; Davoli M
Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD002207. PubMed ID: 24500948
[TBL] [Abstract][Full Text] [Related]
7. Differences between users' and addiction medicine experts' harm and benefit assessments of licit and illicit psychoactive drugs: Input for psychoeducation and legalization/restriction debates.
Bonnet U; Specka M; Kanti AK; Scherbaum N
Front Psychiatry; 2022; 13():1041762. PubMed ID: 36465301
[TBL] [Abstract][Full Text] [Related]
8. Illicit use of opioid substitution drugs: prevalence, user characteristics, and the association with non-fatal overdoses.
Bretteville-Jensen AL; Lillehagen M; Gjersing L; Andreas JB
Drug Alcohol Depend; 2015 Feb; 147():89-96. PubMed ID: 25543167
[TBL] [Abstract][Full Text] [Related]
9. Opioid-related mortality and filled prescriptions for buprenorphine and methadone.
Wikner BN; Öhman I; Seldén T; Druid H; Brandt L; Kieler H
Drug Alcohol Rev; 2014 Sep; 33(5):491-8. PubMed ID: 24735085
[TBL] [Abstract][Full Text] [Related]
10. Diversion of methadone and buprenorphine from opioid substitution treatment: a staff perspective.
Johnson B; Richert T
J Psychoactive Drugs; 2014; 46(5):427-35. PubMed ID: 25364995
[TBL] [Abstract][Full Text] [Related]
11. The complex relation between access to opioid agonist therapy and diversion of opioid medications: a case example of large-scale misuse of buprenorphine in the Czech Republic.
Mravčík V; Janíková B; Drbohlavová B; Popov P; Pirona A
Harm Reduct J; 2018 Dec; 15(1):60. PubMed ID: 30514306
[TBL] [Abstract][Full Text] [Related]
12. Diversion of methadone and buprenorphine from opioid substitution treatment: the importance of patients' attitudes and norms.
Johnson B; Richert T
J Subst Abuse Treat; 2015 Jul; 54():50-5. PubMed ID: 25744650
[TBL] [Abstract][Full Text] [Related]
13. Characterization of diverted buprenorphine use among adults entering corrections-based drug treatment in Kentucky.
Smith KE; Tillson MD; Staton M; Winston EM
Drug Alcohol Depend; 2020 Mar; 208():107837. PubMed ID: 31951906
[TBL] [Abstract][Full Text] [Related]
14. Illicit drug use and injection practices among drug users on methadone and buprenorphine maintenance treatment in France.
Guichard A; Lert F; Calderon C; Gaigi H; Maguet O; Soletti J; Brodeur JM; Richard L; Benigeri M; Zunzunegui MV
Addiction; 2003 Nov; 98(11):1585-97. PubMed ID: 14616185
[TBL] [Abstract][Full Text] [Related]
15. Illicit use of buprenorphine/naloxone among injecting and noninjecting opioid users.
Bazazi AR; Yokell M; Fu JJ; Rich JD; Zaller ND
J Addict Med; 2011 Sep; 5(3):175-80. PubMed ID: 21844833
[TBL] [Abstract][Full Text] [Related]
16. Non-prescribed use of opioid substitution medication: Patterns and trends in sub-populations of opioid users in Germany.
Schulte B; Schmidt CS; Strada L; Götzke C; Hiller P; Fischer B; Reimer J
Int J Drug Policy; 2016 Mar; 29():57-65. PubMed ID: 26818083
[TBL] [Abstract][Full Text] [Related]
17. Diversion of methadone and buprenorphine from opioid substitution treatment: patients who regularly sell or share their medication.
Johnson B; Richert T
J Addict Dis; 2015; 34(1):1-17. PubMed ID: 25496247
[TBL] [Abstract][Full Text] [Related]
18. Uses of diverted methadone and buprenorphine by opioid-addicted individuals in Baltimore, Maryland.
Gwin Mitchell S; Kelly SM; Brown BS; Schacht Reisinger H; Peterson JA; Ruhf A; Agar MH; O'Grady KE; Schwartz RP
Am J Addict; 2009; 18(5):346-55. PubMed ID: 19874152
[TBL] [Abstract][Full Text] [Related]
19. Investigating opioid-related fatalities in southern Sweden: contact with care-providing authorities and comparison of substances.
Andersson L; Håkansson A; Krantz P; Johnson B
Harm Reduct J; 2020 Jan; 17(1):5. PubMed ID: 31918732
[TBL] [Abstract][Full Text] [Related]
20. Non-natural manners of death among users of illicit drugs: Substance findings.
Delaveris GJ; Teige B; Rogde S
Forensic Sci Int; 2014 May; 238():16-21. PubMed ID: 24637034
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
